AAAAAA

   
Results: 1-8 |
Results: 8
Formation of novel D-ring and E-ring isoprostane-like compounds (D-4/E-4-neuroprostanes) in vivo from docosahexaenoic acid
Authors: Reich, EE Zackert, WE Brame, CJ Chen, Y Roberts, LJ Hachey, DL Montine, TJ Morrow, JD
Citation: Ee. Reich et al., Formation of novel D-ring and E-ring isoprostane-like compounds (D-4/E-4-neuroprostanes) in vivo from docosahexaenoic acid, BIOCHEM, 39(9), 2000, pp. 2376-2383
Evidence for the formation of a novel cyclopentenone isoprostane, 15-A(2t)-isoprostane (8-iso-prostaglandin A(2)) in vivo
Authors: Chen, Y Zackert, WE Roberts, LJ Morrow, JD
Citation: Y. Chen et al., Evidence for the formation of a novel cyclopentenone isoprostane, 15-A(2t)-isoprostane (8-iso-prostaglandin A(2)) in vivo, BBA-MOL C B, 1436(3), 1999, pp. 550-556
The isoprostanes: Unique prostaglandin-like products of free-radical-initiated lipid peroxidation
Authors: Morrow, JD Chen, Y Brame, CJ Yang, J Sanchez, SC Xu, J Zackert, WE Roberts, LJ
Citation: Jd. Morrow et al., The isoprostanes: Unique prostaglandin-like products of free-radical-initiated lipid peroxidation, DRUG METAB, 31(1), 1999, pp. 117-139
Cerebrospinal fluid F-2-isoprostanes are elevated in Huntington's disease
Authors: Montine, TJ Beal, MF Robertson, D Cudkowicz, ME Biaggioni, I O'Donnell, H Zackert, WE Roberts, LJ Morrow, JD
Citation: Tj. Montine et al., Cerebrospinal fluid F-2-isoprostanes are elevated in Huntington's disease, NEUROLOGY, 52(5), 1999, pp. 1104-1105
Increased CSF F-2-isoprostane concentration in probable AD
Authors: Montine, TJ Beal, MF Cudkowicz, ME O'Donnell, H Margolin, RA McFarland, L Bachrach, AF Zackert, WE Roberts, LJ Morrow, JD
Citation: Tj. Montine et al., Increased CSF F-2-isoprostane concentration in probable AD, NEUROLOGY, 52(3), 1999, pp. 562-565
Increased formation of thromboxane in vivo in humans with mastocytosis
Authors: Morrow, JD Oates, JA Roberts, LJ Zackert, WE Mitchell, TA Lazarus, G Guzzo, C
Citation: Jd. Morrow et al., Increased formation of thromboxane in vivo in humans with mastocytosis, J INVES DER, 113(1), 1999, pp. 93-97
Prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) induce proliferation of cyclooxygenase-depleted colorectal cancer cells
Authors: Chinery, R Coffey, RJ Graves-Deal, R Kirkland, SC Sanchez, SC Zackert, WE Oates, JA Morrow, JD
Citation: R. Chinery et al., Prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) induce proliferation of cyclooxygenase-depleted colorectal cancer cells, CANCER RES, 59(11), 1999, pp. 2739-2746
Quantification of the major urinary metabolite of 15-F-2t-isoprostane (8-iso-PGF(2 alpha)) by a stable isotope dilution mass spectrometric assay
Authors: Morrow, JD Zackert, WE Yang, JP Kurhts, EH Callewaert, D Dworski, R Kanai, K Taber, D Moore, K Oates, JA Roberts, LJ
Citation: Jd. Morrow et al., Quantification of the major urinary metabolite of 15-F-2t-isoprostane (8-iso-PGF(2 alpha)) by a stable isotope dilution mass spectrometric assay, ANALYT BIOC, 269(2), 1999, pp. 326-331
Risultati: 1-8 |